SBFM

Conviction 62HealthcareScan · Thu, Jun 25, 2026

SBFM$2.14+4.66%

ResistanceSupportVol 14

Vol MA14 256.07K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Sunshine Biopharma Inc.PHARMACEUTICAL PREPARATIONSwww.sunshinebiopharma.com ↗

Price2.14

Change+4.66%

Gap+1.96%

Rel volume0.80×

Avg volume1.8M

Avg $ vol2.61M

SMA 202.08

SMA 501.33

SMA 2001.36

Price vs 50+60.22%

Price vs 200+56.50%

MA stackmixed

50/200 cross—

Supertrendup · 1.50

RSI (14)60

MACD hist-0.05

MACD crossbear · 4d

Stoch %K / %D25 / 12

ADX (14)44

+DI / −DI43 / 17

RSI divergence—

MACD divergence—

ATR %+11.11%

ADR %11.31%

52w high2.66

52w low0.2541

From 52w high-19.74%

Above 52w low+740.22%

New 52w highNo

SqueezeOff

Bollinger width120.44%

%B0.52

Donchian pos67.32%

Donchian high3.05

Donchian low0.2500

AVWAP (52w high)2.60

vs AVWAP high-17.84%

AVWAP (52w low)1.98

vs AVWAP low+7.94%

OBV trendFlat

Chaikin MF (20)-0.49

Today vs 20d0.80×

Avg vol (14d)256.07K

Avg vol (20d)1.8M

Avg $ vol (20d)2.61M

Market cap10.69M

RS 3m (vs SPY)+91.74%

RS 6m (vs SPY)+39.03%

RS line new highNo

Trend template6/8

Technical rank94.3

1 week+0.71%

1 month+412.61%

3 months+107.28%

6 months+54.71%

1 year+43.29%

YTD+66.80%

P/E-1.79

P/B0.50

P/S0.29

P/FCF-1.94

EPS-7.32

Div yield—

ROE-27.77%

ROA-21.39%

Debt/Eq0.10

Current4.22

EV/EBITDA1.19

Gross margin33.76%

Net margin-16.46%

Rev growth4.11%

EPS growth-16.39%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-6.99M

Revenue8.09M

Net income-1.24M

Gross profit2.18M

Free cash flow-5.51M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.12M

Employees50

ListedThu, Aug 9, 2007

Free float4.9M

Float %100.0%

Short interest1.44M

Days to cover0.0d

Short volume46.2%

Squeeze score44 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction62 / 100

Pattern quality—

Tech rank94.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.80

Support0.2656

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SBFM

All disclosures →

No recent disclosed trades by Congress in SBFM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SBFM · 1 buy

Insider	Side	Shares	Value	Traded	Filed
NATAN DAVID Director · Common Stock · 2026-04-14	Grant	100K	$0	2026-04-14	2026-04-14

SEC filings

EDGAR filings in SBFM · 1 recent

EDGAR →

PROXYDEF 14CMon, Jun 8, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.